PhotoMedex to acquire LCA-Vision for $106 million
Click Here to Manage Email Alerts
PhotoMedex and LCA-Vision announced the signing of a definitive agreement for PhotoMedex to acquire LCA-Vision for $5.37 per share in cash, or approximately $106.4 million.
PhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, aestheticians and consumers. LCA-Vision provides laser vision correction services under the Lasik/Plus brand.
The companies announced in a joint press release that upon completion of this transaction, LCA-Vision will operate as a wholly owned subsidiary of PhotoMedex.
LCA-Vision Chief Executive Officer Michael J. Celebrezze said, “The people of PhotoMedex are expert marketers for consumer health, wellness and beauty products with a proven ability to run efficient operations while supporting innovation. Combining our two companies provides for an exciting future for my LCA-Vision colleagues, while offering a compelling premium to LCA-Vision stockholders with the certainty of all-cash terms.”